ANNELIESE PROVOST: Open Payments
NPI 1184173635 · CROPSEYVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 21 payments from 10 companies in 2025. Trend: 2023 $503 · 2024 $453 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| ABBVIE INC. | 4 | $93 |
| Novo Nordisk Inc | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Exact Sciences Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
Products named: FARXIGA, UBRELVY, TRELEGY ELLIPTA, Ozempic, AIRSUPRA, QULIPTA, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across NY — which companies pay providers there.
